Healthcare · Drug Manufacturers - Specialty & Generic

Neuland Laboratories Ltd.

NEULANDLAB

Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

NSE: NEULANDLABOfficial website ↗

Key metrics

Market Cap

₹19,201 cr

P/E Ratio

107.53x

P/B Ratio

12.59x

ROE

17.06%

ROCE

20.94%

Debt / Equity

0.1x

Net Margin

18.13%

Dividend Yield

EPS

₹202.74

Period

FY2025

Shareholding pattern

As of Latest

Promoter: 37.96%FII: 26.97%Public: 35.07%

Deep-dive pages

10-Year Financials→Shareholding Pattern→Dividends & Corporate Actions→

Educational content — not investment adviceThis page presents publicly available information about Neuland Laboratories Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.